Official NIH records · secure checkout · automated delivery
01NIH funding intelligence for specialist lab vendors

Public funding.
Commercially ranked.

Find newly funded labs that match what you sell. Every signal is ranked by explicit evidence, commercial relevance, and uncertainty, with the NIH source attached.

OfficialNIH RePORTER data
≤ 20ranked signals
$39one report
Territory briefFLOW CYTOMETRY · USA
PUBLIC DATA
Strong signals12this window
96
02
TIER BNEW CORE

Flow Cytometry Core

University of North Dakota

89
NO PRIVATE CRM DATA
EVERY CLAIM SOURCED
PUBLIC AWARDSEXPLICIT SIGNALSBUYER-SPECIFIC FITHONEST UNCERTAINTYSOURCE-LINKED OUTPUT
02Configure the answer

Build the brief around your territory.

Select only what matters to your sales motion. The report gets smaller when evidence is weak. It never pads the list to hit a quota.

BRIEF PARAMETERS01 / 04
Funding window
Minimum award shown
AUTOMATED REPORT SCOPEDETERMINISTIC
20
maximum recordsonly records above the evidence threshold
TECHNIQUEFlow cytometryTERRITORYNationalWINDOW30 daysAWARD$100k+
Explicit resource or instrument
New or renewed award
Method-use only

Method-use mentions are excluded by default. A relevant technique is not automatically a buying signal.

03Signal, not noise

Three evidence tiers. One honest boundary.

The raw NIH search is the starting point. The product is the classification, buyer fit, and explicit explanation of what the public record does not prove.

A
STRONGEST SIGNAL

Explicit instrumentation

The award names an instrument or capability and uses a direct instrumentation mechanism.

INVESTIGATE FIRST
B
RESOURCE SIGNAL

New or renewed core

A named core or shared resource received new or competed renewal funding.

QUALIFY THE ROUTE
C
ACCOUNT SIGNAL

Continuing resource

A known facility has an explicit continuing budget, useful for service and account research.

MONITOR, DO NOT ASSUME
04Inside the report

Every row earns its place.

These are real public records from the current feasibility sample. Scores and commercial interpretations are automated FundedLab Radar assessments, not NIH conclusions.

RANKACCOUNT + PROJECTAWARDSIGNALFIT
01TIER A
$249,049Aug 03, 2026New S10 instrumentation award

Strong instrument, installation, training, accessory, and later service relevance.

Vendor selection status is not public.
98/100
02TIER A
$320,191Aug 07, 2026P30 noncompeting continuation

Strong instrument, installation, training, accessory, and service relevance.

The public award does not establish an open purchase.
97/100
03TIER B
$152,280Jul 30, 2026New P30 award

Relevant to core setup or renewal, upgrades, workflow support, training, accessories, and service.

The public award does not establish an open purchase.
83/100
04TIER B
$142,935Aug 03, 2026Competing renewal P30

Relevant to core setup or renewal, upgrades, workflow support, training, accessories, and service.

Installed equipment and purchasing route require verification.
79/100
4 example records shownWeak method-use matches are excludedOfficial API ↗
05The trust boundary

No uploads. No CRM. No invented intent.

01

Verified fact Award, amount, institution, title, date, and source come from NIH.

02

Product assessment Tier, fit, and commercial interpretation are labeled analysis.

03

Unknown stays unknown Vendor selection, procurement timing, and installed equipment are never assumed.

06Concierge validation offer

One useful brief. No platform commitment.

The first version is deliberately small. Choose one territory and capability. Get an automated, source-linked answer after payment.

  • Official NIH award facts and source links
  • Up to 20 ranked records from the stated window
  • Explainable scoring, interpretation, and caveats
  • Web report plus CSV export
FIRST TERRITORY BRIEFONE-TIME
$39per brief

No account required. No subscription. No private business data.

Review scope and buy ↗Payment is handled securely by Stripe. Account access is optional.
07Read before buying

Questions the product should answer plainly.

Are these guaranteed sales leads?

No. They are source-backed accounts worth investigating. The report never claims that a lab is actively buying or that a vendor has not already been selected.

Why pay instead of searching NIH RePORTER?

The raw search returns many projects that merely use a technique. The product applies deterministic deduplication, explicit-signal classification, seller-specific fit, caveats, and a compact territory answer.

What information do I have to share?

Only your territory, what you sell, the award window, and optional inclusion or exclusion phrases. No CRM, proposal, customer list, or account integration is required.

What happens if there are fewer than 20 strong matches?

You receive the smaller honest set. The report will not add weak method-use records to make the list look larger.